Axsome Therapeutics AXSM Total Current Assets
Total Current Assets at other companies
Other financials
Where this comes from
Reported directly by Axsome Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:AssetsCurrent.
The official record: Axsome Therapeutics’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →
Ask your AI about Axsome Therapeutics's total current assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Axsome Therapeutics's total current assets?
- Axsome Therapeutics (AXSM) reported total current assets of $611.21M in Q1 2026.
- How has Axsome Therapeutics's total current assets changed year-over-year?
- Axsome Therapeutics's total current assets increased by 23.6% year-over-year, from $494.63M to $611.21M.
- What is the long-term trend for Axsome Therapeutics's total current assets?
- Over 5 years (2020 to 2025), Axsome Therapeutics's total current assets has grown at a 26.2% compound annual growth rate (CAGR), from $184.02M to $588.99M.
- What does total current assets mean?
- The total value of all company assets that can be turned into cash within one year.
- How do you interpret total current assets?
- A higher total indicates a stronger short-term financial position and greater flexibility to meet upcoming obligations.
- How does total current assets compare across companies?
- Used as a standard benchmark for assessing short-term solvency across all corporate sectors.